OrthoPediatrics launched its initial public offering of 4MM shares of common stock, with a 30-day option for underwriters to purchase up to 600,000 additional shares. The proposed offering price is expected to be between $12 to $14/share, and the company could potentially raise up to $64.0MM. OrthoPediatrics applied to list on NASDAQ as ticker symbol “KIDS.”
Net proceeds will pay accumulated and unpaid dividends on its Series B preferred stock, cover implants and instrument sets for consignment, fund R&D, grow sales and marketing programs and support working capital/general corporate purposes.
OrthoPediatrics launched its initial public offering of 4MM shares of common stock, with a 30-day option for underwriters to purchase up to 600,000 additional shares. The proposed offering price is expected to be between $12 to $14/share, and the company could potentially raise up to $64.0MM. OrthoPediatrics applied to list on NASDAQ as ticker...
OrthoPediatrics launched its initial public offering of 4MM shares of common stock, with a 30-day option for underwriters to purchase up to 600,000 additional shares. The proposed offering price is expected to be between $12 to $14/share, and the company could potentially raise up to $64.0MM. OrthoPediatrics applied to list on NASDAQ as ticker symbol “KIDS.”
Net proceeds will pay accumulated and unpaid dividends on its Series B preferred stock, cover implants and instrument sets for consignment, fund R&D, grow sales and marketing programs and support working capital/general corporate purposes.
Copy to clipboard 
